A cDNA copy of the dengue (DEN) 2 virus genome region encoding the virion capsid, membrane and envelope structural proteins has been inserted into vaccinia virus (VV) DNA under the control of its 11K late promoter. The DEN-2 envelope protein was expressed and processed in cells infected with the VV recombinant (VV/D2S). No DEN-2 virus antibody response was detected in mice, hamsters or monkeys vaccinated with VV/D2S. Furthermore, a viraemia was observed in recombinant-vaccinated monkeys after challenge with infectious DEN-2 virus.
INTRODUCTION
Dengue (DEN) viruses are mosquito-borne flaviviruses which cause human disease throughout tropical and subtropical areas. Each of the four DEN serotypes may cause dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS), a fatal form of the disease that occurs occasionally in children carrying heterologous DEN virus antibodies from a previous infection or from their DEN-immune mother (Halstead, 1980 (Halstead, , 1984 . Halstead (1981) proposed that DHF/DSS results from immune enhancement of infection. Therefore, vaccines may require simultaneous administration of antigens of all four DEN virus serotypes to be effective and not potentiate severe disease. Attenuated DEN vaccines pose problems of virus replication to adequate levels and genetic stability (Sabin & Schlesinger, 1945; Wisseman et al., 1963; Eckels et al., 1980; Bancroft et al., 1984; Halstead et al., 1984; McKee et al., 1987) . Live recombinant vaccinia viruses (VV) that express foreign genes may be an effective way to administer immunogens to humans (Mackett et al., 1984) . To determine whether VV is a suitable vector for expressing an immunogenic envelope glycoprotein (E) of DEN virus, we constructed a recombinant VV containing cDNA encoding the structural proteins of DEN-2 (VV/D2S) and investigated its immunogenicity.
METHODS

Cells and viruses.
The growth and purification of DEN-2 virus strain 1409 (Jamaica 1983) in C6/36 cells was as described by Deubel et.al. (1986) . The DEN-2 strain New Guinea C was used in neutralization tests (NT) in Vero cells and as the challenge virus for mice and hamsters by the intracerebral route of inoculation. DEN-2 virus strain 16681 which is virulent for Cynomolgus sp. monkeys (Halstead & Simasthien, 1970) Health, Wyeth strain) containing the coding sequence for the DEN-2 virus strain 1409 structural proteins (VV/D2S) (Deubel et al., 1986) was isolated by plaque assay in 143B TK-cells in the presence of 30 ttg/ml 5-bromo-2"-deoxyuridine (BUdR). After three successive plaque purifications, VV/D2S was amplified in CV-1 cell monolayers.
Isolation of recombinant VV. The VV shuttle plasmid pKB3 contains part of the VV TK gene interrupted by a unique EcoRI restriction enzyme site adjacent to the P11 late promoter of the 11K VV protein (Sarov & Joklik, 1972; Bertholet et al., 1985; Esposito et al., 1988) . The cDNA of clone p30-VD2 was subcloned into this EcoRI site (Fig. 1) to construct the pKB3-D2S recombinant plasmid containing the DEN-2 structural protein genes (Deubel et al., 1986) .
CV-1 cells were infected with wild-type VV and transfected with calcium phosphate-precipitated pKB3-D2S plasmid DNA. The lysate of the infected cell monolayer was then used to form plaques in BUdR-treated 143B cells, and the plaques were picked, amplified in CV-l cells and screened for expressed DEN-2 virus antigens by indirect immunofluorescence using anti-DEN-2 hyperimmune mouse ascitic fluid. Detection and localization of VV/D2S replication in LLC-MK2 infected cells were determined by in situ hybridization (Singer et al., 1986) using nick-translated 35S-labelled cDNA. The correct insertion and the length of the inserted DEN-2 virus structural genes in VV/D2S were verified by Southern blot hybridization of 32P-labelled nick-translated p30-VD2 probe to HindlII fragments of purified virus DNA (Esposito et al., 1981) .
Analyses of protein synthesis. Twelve h after infection with the recombinant virus, LLC-MK2 cells were labelled with 10 gCi/ml of [3SS]methionine for 12 h. Immunoprecipitation of cell extracts was performed as described by Kessler (1975) . Polypeptides in the precipitate were analysed by SDS-PAGE (12~).
Vaccination, antibody titration, DEN-2 virus challenge. Two sets of female Cynomolgus (Macaca fascicularis) monkeys, 2 to 3.6 kg, were used in the experiments. One set had recovered from a previous yellow fever (YF) virus challenge and had YF-neutralizing antibodies to a titre of 640. The serum of the second group of animals was negative in haemagglutination inhibition (HI) or complement fixation tests against YF, Japanese encephalitis, Uganda S, Opok, Zika and viral antigens of all DEN serotypes. VV or VV/D2S (108 p.f.u.) was administered intradermally in the upper back. One animal of each set was vaccinated subcutaneously with 100 ktg of heat-killed purified 1409 DEN-2 virus mixed with Freund's adjuvant. One month after vaccination, all animals were challenged subcutaneously on the volar surface of the right midarm with 104 p.f.u, of live 16681 DEN-2 virus.
Plasma from each animal was tested daily for viraemia and for antibody response by ELISA (Kaufman et at., 1987) and NT assays (Russell et al., 1967) .
RESULTS
Construction and characterization of VV/D2S
The p30-VD2 cDNA clone coding for the DEN-2 virus-specific structural proteins (Deubel et al., 1986) , was inserted into VV under control of the late 11K promoter of VV. In pKB3, the first translation initiation codon is located just downstream of the P11 promoter sequence and is included in the unique EcoRI site. The foreign gene sequence must, therefore, be in phase with this initiation codon. The Y-non-translated part of the DEN-2 virus genome contains two stop codons (Deubel et al., 1986) . The construction (Fig. 1 ) resulted in a plasmid that contained five codons between the initiation codon of P11 and the first codon of the DEN-2 virus capsid protein. Such a recombinant VV should produce a fusion protein with six additional amino acids at the N terminus of the DEN-2 virus capsid protein. The DEN-2 virus p30-VD2 contained at its 3" end nucleotides coding for the N-terminal 16 amino acids of protein NSI and the cloning G-C tail (Deubel et al., 1986) . The first termination codon occurred 117 nucleotides downstream from the 3' end of the E gene.
VV hybrids containing the DEN-2 virus genes were selected on the basis of their TKphenotype. The location and orientation of the DEN-2 virus structural genes within the VV/D2S genome were confirmed by HindIII digestion of recombinant VV DNA (Fig. 2) . The VV TK gene is located in the 4-5 kbp HindIII J fragment (arrow in Fig. 2 ) which is replaced in VV/D2S DNA by a larger fragment of 4-8 kbp. Because of the internal HindIII site in the DEN-2 viral cDNA sequence (Fig. 1) , an additional DNA fragment of 2-5 kbp is also present in the gel profile (Fig. 2) .
Analysis of transcription and protein expression
The cytoplasmic site of VV/D2S replication 8 h after infection of LLC-MK2 cells was shown by in situ hybridization using DEN-2 cDNA as probe (Fig. 3b) . DEN-2 virus protein was detected by fluorescent antibody in acetone-fixed LLC-MK2 cells 12 to 15 h after infection with VV/D2S (Fig. 3d) . The fluorescence was about fivefold less bright than that of DEN-2 virusinfected cells (Fig. 3c) . Both DEN-2 virus-and VV/D2S-infected cells fluoresced when tested with each of five different anti-DEN virus envelope protein-specific monoclonal antibodies (Table 1) .
Proteins in cells infected with either DEN-2 virus or VV/D2S were examined by PAGE after having been immunoprecipitated with anti-DEN-2 virus polyclonal antibody. One 3SS-labelled v. DEUBEL AND OTHERS 4) . The gel was then stained with ethidium bromide. Southern blot analysis was carried out using p30-VD232p-labelled nick-translated probe (lanes 5 and 6). HindlII J fragment of VV DNA is indicated. The size (kb) of DNA markers is indicated (lane I). Lane 2, VV; lanes 3 and 5, VV DS2; lanes 4 and 6, pKB3-D2S.
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protein (Fig. 4) that was specifically immunoprecipitated from VV/D2S-infected cells (lane 3) comigrated with the virion envelope protein E (lane 1) and with the immunoprecipitated polypeptide from DEN-2 virus-infected cells (lane 2). No band corresponding to the same Mr was detected in VV-infected (lane 4) or mock-infected cells (lane 5).
Neither capsid nor premembrane (prM) or membrane protein was detected in the recombinant VV-infected cells.
I m m u n o g e n i c i t y o f V V / D 2 S f o r a n i m a l s
Four 4-week-old A/J strain mice and outbred hamsters were vaccinated with 108 p.f.u, of VV/D2S by tail scarification or subcutaneous inoculation, respectively. Both mice and hamsters failed to elicit a detectable anti-DEN-2 virus antibody response after immunization with the recombinant (data not shown). No challenge test in either of these two species was possible since DEN-2 virus does not cause a high-titre viraemia or clinical symptoms in mice or hamsters. C y n o m o l g u s monkeys are very susceptible to DEN-2 virus and develop a high-titre viraemia when inoculated with the 16681 strain of DEN-2 virus (Angsubhakorn et al., 1987) . Eight monkeys were segregated in two groups: flavivirus antibody-free and YF-immune animals ( Table 2) T a b l e 1. t Anti-E monoclonal antibodies (Gentry et al., 1982) .
Immunofluorescence of expressed DEN-2 virus envelope protein E in acetone-fixed LLC-MK2 cells infected with DEN-2 virus, VV/D2S or VV, using anti-E mouse monoclonal antibodies
lesion of 15 m m or 8 m m d i a m e t e r d e v e l o p e d at the site of v a c c i n a t i o n w h e n a n i m a l s were v a c c i n a t e d w i t h V V or V V / D 2 S , respectively. F o u r weeks after i m m u n i z a t i o n , N T a n t i b o d y titres to V V were l0 to 40. As previously o b s e r v e d in the m o u s e a n d h a m s t e r e x p e r i m e n t s , n o N T a n t i b o d y to D E N -2 virus was detected in a n y of the V V / D 2 S -i m m u n i z e d m o n k e y s . Only t h e m o n k e y t h a t h a d previous Y F a n t i b o d i e s s h o w e d a low titre of a n t i -D E N -2 virus a n t heat-killed DEN-2 virus showed anti-DEN-2 virus antibodies as determined by both NT and ELISA assays (Table 2) . One month after vaccination, all monkeys were challenged with 10 ~ p.f.u, of live DEN-2 virus. Monkeys vaccinated with inactivated DEN-2 virus did not develop a viraemia during 6 days post-challenge ( Table 2 ). Monkeys that had pre-existing YF antibodies showed a low and short DEN viraemia. The VV/D2V-immunized monkeys that had no antiflavivirus antibodies at the time of the DEN virus challenge experienced a 4 to 5 day viraemia (Table 2) . Animals vaccinated with VV/D2S had a viraemia equal in duration and titre to that of the unvaccinated or VV-vaccinated control monkeys ( Table 2 ). The post-challenge anti-DEN-2 virus antibody levels in these animals reached serum NT titres of 40 to 80, indicating that they had not had an anamnestic response because the monkey vaccinated with DEN-2 virus had a serum NT titre of only 160. In contrast, anti-DEN-2 virus antibody titres in monkeys that had YF antibody before DEN-2 virus challenge showed a secondary response after DEN virus challenge (Table 2) . DISCUSSION Vaccinia virus recombinants can be used to express various foreign virus proteins (Ball et al., 1986; Mackett et al., 1984; Wiktor et al., 1984) , and such proteins have been shown to be immunogenic in animals. Zhao et al. (1987) reported that a VV recombinant expressing the structural and NS1 proteins of DEN-4 virus failed to elicit an antibody response in cotton rats. These authors suggested that a VV promoter other than 7.5K might provide a more efficient expression of the DEN virus proteins. We have developed an infectious VV recombinant, VV/D2S, that encodes the DEN 2 virus structural genes under the control of VV late 11K promoter. Immunofluoresence and immunoprecipitation tests using VV/D2S-infected cells showed that the E protein was processed and contained antigenic determinants in common with the authentic E protein expressed in DEN-2 virus-infected cells. This suggested that the maturation of this protein occurred by proteolytic cleavage of the polyprotein in the absence of dengue virus functions provided by the non-structural proteins (Rice et al., 1985) . Although DEN virus envelope E protein was detectable in infected cells 12 h after infection, we were unable to detect expression of the protein on the cell surface, either by immunofluorescence tests of unfixed cells or by immune cytolysis (Catanzaro et al., 1974) .
We have confirmed in YF virus-preimmune monkeys that a flavivirus group-reactive neutralization epitope may exist (Deubel et al., 1986) , which helps explain the cross-protection between YF and DEN viruses (Theiler & Anderson, 1975) . A group-reactive epitope common to DEN and YF viruses has also been suggested in DEN virus-vaccinated YF preimmune human recipients (Bancroft et al., 1981 (Bancroft et al., , 1984 .
The failure of DEN vaccination using a VV recombinant is not well understood. The expression level of protein E, its expression on the cell surface, and the site of VV replication may play important roles. Further investigation will be required to resolve the difficulties of immunogenic expression of flavivirus proteins by recombinant VV.
